United Launch Alliance Will Use CDI’s DSPCon Test and Measurement Solutions for Mission-Critical Tests on Orion’s Launch Systems CDI Corp. (NYSE: CDI) announced today that its DSPCon subsidiary has ...

Hackensack Meridian Health announced Tuesday that a rapid test for COVID-19 created by its labs at the Center for Discovery and Innovation (CDI) has been licensed to T2 Biosystems, a ...

Simply adding an admission screening question and a 2-step testing algorithm sharply decreased the number of Clostridioides difficile infections (CDI) in the year after implementing the interventions.

Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, is pleased to announce that the Center for Discovery and Innovation (CDI) has created a test to dramatically ...

Testing for Clostridium difficile infection is significantly lower than expected during diagnosis of inflammatory bowel disease, according to a study in Inflammatory Bowel Diseases, the official ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Significant differences existed between ...

Clostridium bacteria, computer illustration. Clostridia are spore-forming bacteria that include several human pathogenic species, C. difficile, C. tetani, C. botulinum, C. perfringens, and others. C.

There's no foolproof way to know the future for CDI (NYS: CDI) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a ...